About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Popular Breast Cancer Drug ‘could Make Disease More Aggressive’

by VR Sreeraman on December 5, 2008 at 3:00 PM
Font : A-A+

 Popular Breast Cancer Drug ‘could Make Disease More Aggressive’

For some women, a leading breast cancer drug, called Tamoxifen, could make the disease more aggressive, according to scientists.

Considered as a "gold standard" for breast cancer treatment, Tamoxifen has been used to combat the disease for more than 20 years and has been credited with saving the lives of around 20,000 women since the 1980s.

Advertisement

But now, scientists have conducted laboratory tests on cancer cells grown in test tubes and found evidence indicating that giving Tamoxifen to some patients could actually promote the disease.

It was found that adding Tamoxifen to cancer cells which contained low levels of a naturally-produced protein, called E-cadherin, caused the cells to behave more aggressively.
Advertisement

Lead researcher, Dr Stephen Hiscox, from the Welsh School of Pharmacy at Cardiff University, said that they were unaware of the percentage of patients who would have low levels of the protein in their bodies.

"Certainly the vast majority appear to have normal levels," The Telegraph quoted him as saying.

He added: "Also, we do not at this stage know what level is low enough for this effect to kick in, or indeed whether there is the same effect in humans as we are finding in laboratory tests."

Currently, the researchers are examining samples from breast cancer patients to try to work out what proportion of women have low levels of the protein.

He claimed that such patients could potentially be treated instead with a new class of drugs, called aromatase inhibitors, which target the cancer differently by depriving the body of oestrogen, which helps to fuel the growth of tumours.

According to the scientists Tamoxifen could react with low levels of E-cadherin in the body and elevate the amount of another protein, called SRC.

In earlier studies, SRC was shown to affect breast cancer cells to make them behave more aggressively.

The study is published in the journal Breast Cancer Research.

Source: ANI
LIN
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Advertisement
News Category
What's New on Medindia
Top 7 Benefits of Good Oral Hygiene
Healthy and Safer Thanksgiving 2021
Long-Term Glycemic Control - A Better Measure of COVID-19 Severity
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Women and Cancer Drug Toxicity Breast Biopsy Pagets disease of the breast Mastitis Cancer and Homeopathy Signature Drug Toxicity Breast Cancer Facts Cancer Facts Cancer 

Recommended Reading
Breast Self Examination - Animation
Slides and animation of Breast Self Examination for early detection of breast cancer lumps in ......
Tamoxifen
This medication is an antiestrogen, prescribed for breast cancer. It is also used for ......
Breast Biopsy
Breast biopsy involves removing a sample of breast tissue to determine whether it is cancerous or .....
Drug Toxicity
Drug toxicity is an adverse reaction of the body towards a drug that results as a side effect of a d...
Mastitis
Mastitis is a common cause of tenderness, swelling and pain in breast, owing to inflammation in the ...
Pagets disease of the breast
A detailed description of the Paget's disease of the breast, characteristic signs and symptoms, dete...
Women and Cancer
Cancer is one of the frequently talked about and most feared disease that falls under the genre of l...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use